|

30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital

RECRUITINGN/ASponsored by Komfo Anokye Teaching Hospital
Actively Recruiting
PhaseN/A
SponsorKomfo Anokye Teaching Hospital
Started2025-07-14
Est. completion2026-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07100561

Summary

In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* · Adults Aged 18 years and above

  * Diagnosed with heart failure
  * NYHA Class II-IV
  * Informed consent

Exclusion Criteria:

* · NHYA class I

  * Patients who do not have access to a mobile phone

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.